K. Kesh

发表

Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.

Alice Nomura, S. Bhattacharya, A. Saluja, 2018, Cancer letters.

A common tag nucleotide variant in MMP7 promoter increases risk for hypertension via enhanced interactions with CREB transcription factor

N. Mahapatra, A. Mullasari, Saurabh Sharma, 2019, bioRxiv.

Hypoxia driven oncometabolite L-2HG maintains “stemness”-differentiation balance and facilitates immune suppression in pancreatic cancer

P. Singh, B. Durden, A. Saluja, 2020, bioRxiv.

Microbial Dysbiosis and polyamine metabolism as predictive markers for early detection during progression of pancreatic adenocarcinoma in spontaneous mouse model

N. Merchant, L. Martino, F. McAllister, 2018 .

Targeting tumor-intrinsic metabolic node sensitizes pancreatic cancer to anti-PD1 therapy

B. Durden, A. Saluja, Vineet Gupta, 2019, bioRxiv.

Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants World Journal of Biological Chemistry

S. Swarnakar, Sayantan Jana, Sayantan, 2014 .

Association of MMP7 −181A→G Promoter Polymorphism with Gastric Cancer Risk

N. Mahapatra, S. Swarnakar, Vinayak Gupta, 2015, The Journal of Biological Chemistry.

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability

C. Slawson, A. Saluja, S. Vickers, 2019, Theranostics.

O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancer

C. Slawson, A. Saluja, S. Vickers, 2018, bioRxiv.

A Common Tag Nucleotide Variant in MMP7 Promoter Increases Risk for Hypertension via Enhanced Interactions With CREB (Cyclic AMP Response Element-Binding Protein) Transcription Factor.

N. Mahapatra, A. Mullasari, Saurabh Sharma, 2019, Hypertension.

Attenuation of Helicobacter pylori-induced gastric inflammation by prior cag− strain (AM1) infection in C57BL/6 mice

A. Mukhopadhyay, S. Swarnakar, K. Kesh, 2017, Gut Pathogens.

OPIOID USE IN MURINE MODEL RESULTS IN SEVERE GASTRIC PATHOLOGY THAT MAY BE ATTENUATED BY PROTON PUMP INHIBITION.

Sabita Roy, S. Ramakrishnan, K. Kesh, 2022, The American journal of pathology.

Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.

S. Swarnakar, Sayantan Jana, K. Kesh, 2014, World journal of biological chemistry.

Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded

B. Durden, Sulagna Banerjee, K. Kesh, 2020, Cancers.

Labeling Cancer Stem Cells with 13C6 Glucose and 13C5 Glutamine for Metabolic Flux Analysis.

Sulagna Banerjee, K. Kesh, 2019, Methods in molecular biology.

Long non-coding RNA GAS5 acts as proliferation “brakes” in CD133+ cells responsible for tumor recurrence

B. Durden, A. Saluja, Sulagna Banerjee, 2019, bioRxiv.

Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer

P. Singh, B. Durden, S. Bhattacharya, 2021, Cancer Research.

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways

B. Durden, N. Merchant, A. Saluja, 2020, Cell Death & Disease.

An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk.

S. Swarnakar, K. Kesh, Arnab Gupta, 2015, Asian Pacific journal of cancer prevention : APJCP.

Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma

Leila Abdelrahman, Santanu Banerjee, Sulagna Banerjee, 2020, Microbial Cell Factories.

Matrix Metalloproteinase-1 (MMP-1) Promoter Polymorphisms are Well Linked with Lower Stomach Tumor Formation in Eastern Indian Population

S. Swarnakar, K. Kesh, Arnab Gupta, 2014, PloS one.

Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population

S. Swarnakar, K. Kesh, Arnab Gupta, 2012, Molecular carcinogenesis.

Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.

B. Durden, A. Saluja, Sulagna Banerjee, 2019, The Journal of clinical investigation.

Morphine use induces gastric microbial dysbiosis driving gastric inflammation through TLR2 signalling which is attenuated by proton pump inhibition

Sabita Roy, Umakant Sharma, S. Ramakrishnan, 2022, British journal of pharmacology.

Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.

A. Saluja, S. Vickers, Sulagna Banerjee, 2018, Cancer research.

Microbial Dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer

N. Merchant, F. McAllister, Sulagna Banerjee, 2018, bioRxiv.

Chronic pancreatitis in a caerulein-induced mouse model is associated with an altered gut microbiome.

R. Dawra, V. Dudeja, K. Kesh, 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression, remodels extracellular matrix and sensitizes to anti-PD1 therapy.

B. Durden, A. Saluja, Sulagna Banerjee, 2019 .

Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC

B. Durden, N. Merchant, Santanu Banerjee, 2022, Gut microbes.

Diet induced hyperlipidemia confers resistance to standard therapy in pancreatic cancer by selecting for “tumor protective” microbial metabolites and treatment refractory cells

B. Durden, N. Merchant, Santanu Banerjee, 2021, bioRxiv.

Microbial Dysbiosis and polyamine metabolism as predictive markers for early detection during progression of pancreatic adenocarcinoma in spontaneous mouse model

L. Martino, F. McAllister, K. Kesh, 2022 .